Skip to main content
SpringerLink
Log in

Exubera labelling update regarding lung cancer

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Pfizer Inc.EXUBERA (Rm) (insulin human [rDNA origin] Inhalation Powder) labeling update. Internet Document: [2 pages], 9 Apr 2008. Available from: URL: http://www.fda.gov

  2. Pfizer Inc.Important safety information about Exubera (Rm) (insulin human [rDNA origin] Inhalation Powder. Internet Document: [2 pages], 9 Apr 2008. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Exubera labelling update regarding lung cancer. React. Wkly. 1198, 3 (2008). https://doi.org/10.2165/00128415-200811980-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200811980-00007

Keywords

Search

Navigation